Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGaming Realms Regulatory News (GMR)

Share Price Information for Gaming Realms (GMR)

Share Price is delayed by 15 minutes
Get Live Data
30.00    -0.40 (-1.32%)
Bid:
30.00
Ask:
30.50
Spread: 0.50 (1.667%)
Market Cap: £81.82m
GMR Live PriceLast checked at - London Stock Exchange

Intraday Gaming Realms Share Chart

Biofuels Update

18 Mar 2011 07:06

RNS Number : 1999D
Pursuit Dynamics PLC
18 March 2011
Β 

ο»Ώ

18 March 2011

Β 

Pursuit Dynamics PLC (AIM: PDX)

("PDX" or the "Company')

Β 

Biofuels update

Β 

PDX is pleased to announce today that it has agreed to formal terms with Pacific Ethanol Columbia LLC for the commercial operation of the Ethanol Reactor System ("ERS") installation at its Columbia Plant near Boardman, Oregon (USA). The agreement, which is in line with previous guidance, ensures that PDX would share in the full range of benefits that accrue to Pacific Ethanol Columbia through operating the ERS, which we believe will include an enhanced yield, reduced operating cost, reduced enzyme costs and improved cycle times.

Β 

Commenting on the announcement, Neil Koehler, CEO of Pacific Ethanol, Inc. (NASDAQ CM: PEIX), which manages the plant, stated:

Β 

"The agreement with PDX enables the continued operation of the ERS and verification of the benefits it delivers at the Pacific Ethanol Columbia plant in Boardman, Oregon. We are pleased to advance our relationship with PDX as it demonstrates our continued focus on introducing new technology that will enable us to enhance the yields on corn ethanol and optimizing the overall performance of our ethanol production plants."

Β 

Commenting on the announcement, Roel Pieper, CEO of PDX said:

Β 

"Today's announcement is the culmination of a tremendous amount of hard work on behalf of the team who have worked diligently and tirelessly to demonstrate the ERS's commercial potential. We now look forward to growing the business further and continuing to drive commercial returns."

Β 

- Ends -

Β 

For Further Information, please contact:

Β 

PDX

Roel Pieper, CEO

Tel: +44 (0)1480 422050

Richard Webster, CFO

Financial Dynamics

Ben Foster

Marc Cohen

Tel: +44 (0) 20 7831 3113

Tel: +44 (0) 7802 877 241

Β 

Β 

Cenkos Securities

Ian Soanes

Max Hartley

Tel: +44 (0)20 7397 8924

Mirabaud Securities

Rory Scott

Tel: +44 (0) 20 7878 3360

Β 

Β 

Notes to Editors

Β 

About PDX

Β 

- PDX (AIM: PDX) owns and commercialises the PDX Atomiser and Reactor technologies that enable significant reductions in energy usage, process acceleration and result enhancement for a wide range of industrial processes and applications.

Β 

- The PDX business model is currently organised into six Lines of Business - Biofuels; Brewing, Food and Beverages; Public Health and Decontamination; Industrial Licensing; Water and New Ventures.

Β 

- PDX is headquartered in Huntingdon (UK) with an office in London (UK), Schaffhausen (Switzerland) and Connecticut (USA).

Β 

- Further information is available at the Company's website: www.pdx.bizΒ 

Β 

- Publication quality photographs are available from FD.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCDVLBFFXFBBBE
Date   Source Headline
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNS-RInvestor Presentation
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSAnnual Results 2025
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSUpdate on Share Buyback Programme
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:01 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSFY25 Pre-Close Trading Update
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.